Earnings · China A-shares
Chongqing Zhifei Biological Products Co., Ltd. Class A (300122) earnings
Chongqing Zhifei Biological Products Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit +48.55% year on year, +43.99% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -1.30% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- +48.55%
- Excl. one-offs YoY
- +43.99%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.15% | — |
| 3 days | -1.30% | — |
| 7 days | +12.95% | — |
| 14 days | +6.13% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -2.07%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | -¥683.25M | +48.55% | +43.99% | -14.46% | -0.29 | -4.41% | -1.30% | — | — |
| 2026 interim report | 2026-08-29 | -¥808.51M | -33.35% | -29.53% | -18.36% | -0.34 | -5.24% | -3.94% | -12.11% | -2.78% |
| 2026 Q1 report | 2026-04-28 | -¥388.32M | -18.79% | -15.62% | -8.64% | -0.16 | -2.48% | +1.47% | -17.21% | -16.59% |
| 2025 annual report | 2026-04-28 | -¥14.72B | -846.42% | — | -65.61% | -6.15 | -62.67% | +1.47% | -17.21% | -16.59% |
| 2025 Q3 report | 2025-10-30 | -¥1.33B | -156.86% | — | -66.45% | -0.55 | -3.99% | +2.27% | -2.12% | +2.62% |
| 2025 interim report | 2025-08-19 | -¥598.08M | -126.62% | — | -73.05% | -0.25 | -1.96% | -1.61% | -11.80% | -20.98% |
| 2025 Q1 report | 2025-04-22 | -¥326.91M | -120.93% | — | -79.38% | -0.14 | -1.07% | -9.30% | -10.22% | -13.09% |
| 2024 annual report | 2025-04-22 | ¥1.97B | -75.26% | -75.12% | -50.82% | 0.82 | 6.41% | -9.30% | -10.22% | -13.09% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.